Literature DB >> 15535793

Evaluating the endophenotype model of ADHD neuropsychological deficit: results for parents and siblings of children with ADHD combined and inattentive subtypes.

Joel T Nigg1, Lisa G Blaskey, Julie Ann Stawicki, Jennifer Sachek.   

Abstract

Neurogenetic models predict neuropsychological weaknesses in the relatives of children with attention-deficit/ hyperactivity disorder (ADHD). The authors examined executive and regulatory measures in 386 relatives (307 parents, 79 siblings) of children with ADHD combined type, ADHD inattentive type, and controls. Predicted deficits were seen on trailmaking (relatives of ADHD combined type only), stop-signal reaction times (relatives of girls only), and response variability (mothers only) but not on naming or output speed. Effects generally held, even with relatives' ADHD status controlled. A neuropsychologically impaired subgroup of children with ADHD had relatives with clear neuropsychological weaknesses. The authors conclude that a neurogenetic model of ADHD etiology is supportable only for a subset of executive functions and that neuropsychological heterogeneity warrants more examination in ADHD. Copyright 2004 APA.

Entities:  

Mesh:

Year:  2004        PMID: 15535793     DOI: 10.1037/0021-843X.113.4.614

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  64 in total

1.  The shifting subtypes of ADHD: classification depends on how symptom reports are combined.

Authors:  Andrew S Rowland; Betty Skipper; David L Rabiner; David M Umbach; Lil Stallone; Richard A Campbell; Richard L Hough; A J Naftel; Dale P Sandler
Journal:  J Abnorm Child Psychol       Date:  2008-03-18

2.  Are motor inhibition and cognitive flexibility dead ends in ADHD?

Authors:  Nanda N J Rommelse; Marieke E Altink; Leo M J de Sonneville; Cathelijne J M Buschgens; Jan Buitelaar; Jaap Oosterlaan; Joseph A Sergeant
Journal:  J Abnorm Child Psychol       Date:  2007-05-15

Review 3.  The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks.

Authors:  Dawn M Eagle; Andrea Bari; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

4.  Individual differences in executive functions are almost entirely genetic in origin.

Authors:  Naomi P Friedman; Akira Miyake; Susan E Young; John C DeFries; Robin P Corley; John K Hewitt
Journal:  J Exp Psychol Gen       Date:  2008-05

Review 5.  Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance.

Authors:  Cynthia L Huang-Pollock; Sarah L Karalunas; Helen Tam; Amy N Moore
Journal:  J Abnorm Psychol       Date:  2012-03-19

Review 6.  The neurobiological profile of girls with ADHD.

Authors:  E Mark Mahone; Ericka L Wodka
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Intra-individual variability among children with ADHD on a working memory task: an ex-Gaussian approach.

Authors:  Wendy M Buzy; Deborah R Medoff; Julie B Schweitzer
Journal:  Child Neuropsychol       Date:  2009-09       Impact factor: 2.500

8.  SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.

Authors:  S H Kollins; A D Anastopoulos; A M Lachiewicz; D FitzGerald; E Morrissey-Kane; M E Garrett; S L Keatts; A E Ashley-Koch
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

9.  A lack of default network suppression is linked to increased distractibility in ADHD.

Authors:  Catherine Fassbender; Hao Zhang; Wendy M Buzy; Carlos R Cortes; Danielle Mizuiri; Laurel Beckett; Julie B Schweitzer
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

Review 10.  Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.

Authors:  Dawn M Eagle; Christelle Baunez
Journal:  Neurosci Biobehav Rev       Date:  2009-07-15       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.